The clinical and microbiome characteristics study in post-HSCT infection of children with leukemia and thalassemia

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100042364

Enrollment

Unknown

Registered

2021-01-21

Start date

2021-01-17

Completion date

Unknown

Last updated

2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood acute lymphoblastic leukemia and thalassemia

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Age

1 Years to 18 Years

Inclusion criteria

Inclusion criteria: (1) Aged <= 18 years; (2) Patients were diagnosed with transfusion-dependent thalassemia, acute myeloid leukemia, and acute lymphoblastic leukemia; (3) First time recipient of myeloid hematopoietic stem cell transplantation; (4) Signed the informed consent for hematopoietic stem cell transplantation and the consent for the use of discarded medical samples; (5) Signing the informed consent for the study.

Exclusion criteria

Exclusion criteria: (1) Accompanied with active infection before transplantation; (2) Leukemia secondary to immunodeficiency disease; (3) Second tumor, secondary transplantation.

Countries

China

Contacts

Public ContactJian-Pei Fang

Sun Yat-Sen Memorial Hosipital

jpfang2005@163.com+86 13682290830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026